MYL-1701Pafliberceptdiabetic macular oedemaNCT03610646
… MYL-1701P and those who switched from reference aflibercept to MYL-1701P in the 20-week extension study of the pivotal trial.Trial regis…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: MYL-1701P ×
MYL-1701P
This drug is selected. Its supporting articles are shown below.